How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow. Nasdaq Listings Host Kristina Ayanian delves into companies' notable accomplishments, ...

Three killed, four others wounded in Seattle food festival shooting, police say Three people were killed and four others, including a toddler, were wounded on Sunday in a shooting at ‌a downtown ...

Instead of competitive multiplayer, Splatoon Raiders has you take on fishlike enemies with an array of weapons and gadgets. By Yussef Cole Backyard Baseball, a favorite game for 1990s kids, had been ...

Important: Double-check the numbers before submitting your entry. If an incorrect number is reported, you will not be able to edit it on your Student Center and will need to use the Student Personal ...

The latest fashion news, beauty coverage, celebrity style, fashion week updates, culture reviews, and videos on Vogue.com.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

We think these stocks have gotten ahead of themselves.